Déficit de atenção e hiperatividade: prevenindo o sobrediagnóstico e o sobretratamento

Jean-Claude St-Onge

Resumo


A primeira parte deste artigo concentra-se nas grandes variações no diagnóstico de transtorno de déficit de atenção e hiperatividade (TDAH), que são observadas entre países e entre regiões de um mesmo país. O diagnóstico de TDAH é mais problemático do que normalmente se pensa. Por exemplo, crianças norte-americanas mais jovens no mesmo grau escolar são 64% mais propensas a receber o diagnóstico e os sintomas podem resultar de muitas causas subjacentes. Além disso, o TDAH pode ser confundido com muitas outras questões de saúde. Como resultado, o TDAH é amplamente sobrediagnosticado e sobretratado. A segunda parte do artigo revisa estudos recentes que mostram que as drogas anti-TDAH não têm eficácia de longo prazo e contam com eventos adversos importantes. No geral, e no longo prazo, o tratamento farmacológico do TDAH é susceptível de causar maiores danos do que benefícios.

Palavras-chave


Transtorno do Déficit de Atenção com Hiperatividade; Medicalização Efetividade; efeitos adversos; Prevenção Quaternária

Texto completo:

PDF/A (English)

Referências


Centers for Disease Control and Prevention (CDC). Data and statistics. New data: medication and behavior treatment [Internet]. Clifton Road Atlanta, GA: United States. U.S. Department of Health & Human Services; 2015 [cited 2015 Jun 18]. Available from: http://www.cdc.gov/ncbddd/adhd/data.html

Cohen D. ADHD in France and in America [Internet]. In: Mad in America: Science, Psychiatry and Community. 2013 [cited 2013 Sept 30]. Available from: http://www.madinamerica.com/2013/09/adhd-france-america/

Von Blech J. Schwermut ohne Scham. Der Spiegel, 2012 Jun 2. 2015 [cited 2015 June 18] Available from: http://www.spiegel.de/spiegel/print/d-83865282.html.

Rettner R. Doc Shouldn’t Give ADHD Drugs to Healthy Kids [Internet]. In: Live Science. 2013 [cited 2013 Mar 13]. Available from: http://www.livescience.com/27884-adhd-drugs-healthy-kids-prescribing.html

Papin F. “N’achetez pas le DSM-5”, recommande le Dr Allen Frances, père du DSM-IV [Internet]. In: Institut du développement de l’enfant et de la famille. 2013 [cited 2013 Sep 30]. Available from: https://www.facebook.com/permalink.php?story_fbid=10151899309383841&id=252682718840

Haute Autorité de Santé. Conduite à tenir devant un enfant ou un adolescent ayant un déficit de l’attention et/ou un problème d’agitation. 2012 [cited 2015 Jun 18]. Available from: http://www.afpssu.com/wp-content/uploads/2013/07/trouble-de-lattention-de-lenfant_note_de_cadrage.pdf

Institut de la statistique du Québec. L’Enquête québécoise sur la santé des jeunes du secondaire. Tome 2: Le visage des jeunes d’aujourd’hui: leur santé mentale et leur adaptation sociale 2010-2011. Québec, FR: Institut de la statistique du Québec; 2013.

Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 1998;351(9100):429-433.[Accessed Jun 18 2015]. http://dx.doi.org/10.1016/S0140-6736(97)11450-7. PMid:9482319.

Gonon F, Cohen D. Le trouble déficitaire de l’attention avec hyperactivité : La génétique est-elle impliquée? Med Sci (Paris). 2011;27(3):315-317. http://dx.doi.org/10.1051/medsci/2011273315. PMid:21447307.

Kupfer D. Statement by David Kupfer, MD [Internet]. In: American Psychiatric Association. Arlington, VA: American Psychiatric Association; 2013 [Accessed: Jun 18 2015]. Available from: http://www.psych.org/File%20Library/Advocacy%20and%20Newsroom/Press%20Releases/2013%20Releases/13-33-Statement-from-DSM-Chair-David-Kupfer--MD.pdf

Guay MC, Lageix P, Parent V. Proposition d’une démarche évaluative du TDAH. In: Chevalier N, Guay MC, Achim A, Lageix P, Poissant H, editors. Trouble déficitaire de l’attention avec hyperactivité. Soigner, éduquer, surtout valoriser. Montréal: l’Université du Québec; 2006. 5 p.

Elder TE. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J Health Econ. 2010;29(5):641-656. http://dx.doi.org/10.1016/j.jhealeco.2010.06.003. PMid:20638739.

Dotinga R. Youngest kids in class may be more likely to get ADHD diagnosis [Internet]. In: Health Day. 2012 [cited 2015 Jun 18]. Available from: http://consumer.healthday.com/kids-health-information-23/attention-deficit-disorder-adhd-news-50/youngest-kids-in-class-may-be-more-likely-to-get-adhd-diagnosis-670784.html

Holmberg K, Sundelin C, Hjern A. Screening for attention-deficit/hyperactivity disorder (ADHD): can high-risk children be identified in first grade? Child Care Health Dev. 2013;39(2):268-276. http://dx.doi.org/10.1111/j.1365-2214.2012.01382.x. PMid:22515618.

Thomas R, Mitchell GK, Batstra L. Attention-deficit/hyperactivity disorder: are we helping or harming? BMJ. 2013;347:f6172. [Accessed: 2015 Feb 3]. http://dx.doi.org/10.1136/bmj.f6172. PMid:24192646.

Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr. 1998;19(3):162-168. http://dx.doi.org/10.1097/00004703-199806000-00003. PMid:9648041.

Parens E, Johnston J. Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies. Child Adolesc Psychiatry Ment Health. 2009;3(1):1-17. http://dx.doi.org/10.1186/1753-2000-3-1. PMid:19152690.

Thakkar VG. Diagnosing the wrong deficit [Internet]. In: The New York Times Sunday Review. 2013 [cited 2013 Apr 27]. Available from: http://www.nytimes.com/2013/04/28/opinion/sunday/diagnosing-the-wrong-deficit.html?emc=eta1&_r=0.

Saul R. Doctor: ADHD does not exist [Internet]. In: Time. 2004 [cited 2015 Jun 18]. Available from: http://time.com/25370/doctor-adhd-does-not-exist/

Canadian ADHD Practice Guidelines (CAP-Guidelines) [Internet]. 3rd ed. Canada: Canadian ADHD Resource Alliance; 2010 [cited 2015 Jun 18y]. Available from: http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011.pdf

Sroufe A. Ritalin Gone Wrong [Internet]. In: The New York Times Sunday Review. 2012 [cited 2012 Jan 28]. Available from: http://www.nytimes.com/2012/01/29/opinion/sunday/childrens-add-drugs-dont-work-long-term.html.

Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006;114(12):1904-1909. PMid:17185283.

Kirk SA, Gomory T, Cohen D. Mad Science: psychiatric coercion, diagnosis, and drugs. New Brunswick, NJ: Transaction Publishers; 2013. 166 p.

Insel T. Transforming Diagnosis [Internet]. In: National Institute of Mental Health. 2013 [cited 2015 Jun 18y]. Available from: http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml

The Trumpet. Psych Illnesses Lack Scientific Basis [Internet]. 2007 [cited cited 2015 Jun 18]. Available from: http://www.thetrumpet.com/article/3819.2061.96.0/society/psych-illnesses-lack-scientific-basis?preview

Food and Drug Administration (FDA). Inspections, compliance, enforcement, and criminal investigations [Internet]. 2008 [cited 2008 Sept 25]. Available from: http://www.fda.gov/iceci/enforcementactions/warningletters/2008/ucm1048119.htm

Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484-500. http://dx.doi.org/10.1097/CHI.0b013e31819c23d0. PMid:19318991.

Smith G, Jongeling B, Hartmann P, Russell C, Landau L. Raine ADHD study: long-term outcomes associated with stimulant medication in the treatment of ADHD in children [Internet]. Austrália: Government of Western Australia; 2010 [cited 2015 Jun 18]. Available from: https://www.health.wa.gov.au/publications/documents/MICADHD_Raine_ADHD_Study_report_022010.pdf

Case Western Reserve University. FDA approves many drugs that predictably increase heart and stroke risk: case western reserve physician calls on FDA to address hidden risk [Internet]. 2014 [cited 2014 May 24]. Available from: http://casemed.case.edu/newscenter/news-release/newsrelease.cfm?news_id=212

Currie J, Stabile M, Jones LE. Do stimulant medications improve educational and behavioral outcomes in children with ADHD? Massachusetts: National Bureau of Economic Research; 2013 [cited 2015 Jun 18]. Available from: https://www.mcgill.ca/socialstatistics/files/socialstatistics/mark_stabile_oct_2_2013.pdf

Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L, et al. The preschool attention-deficit/hyperactivity disorder treatment study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry. 2013;52(3):264-278. http://dx.doi.org/10.1016/j.jaac.2012.12.007. PMid:23452683.

Collingwood J. Side effects of ADHD medication [Internet]. In: PsychCentral. 2010 [cited 2015 Jun 18]. Available from: http://psychcentral.com/lib/side-effects-of-adhd-medications/0003782

St-Onge JC. Tous fous? L’influence de l’industrie pharmaceutique sur la psychiatrie. Montréal: Écosociété; 2013. 78 p.

Bruser D, Bailey A. ADHD drugs suspected of hurting canadian kids [Internet]. In: Toronto Star Newspapers. 2012 [cited 2012 Sept 26]. Available from: http://www.thestar.com/news/canada/2012/09/26/adhd_drugs_suspected_of_hurting_canadian_kids.html

Institute for Safe Medication Practices (ISMP). QuarterWatch Monitoring FDA MedWath Reports. Horsham; 2015 [cited 2015 June 18] Available from: http://www.ismp.org/QuarterWatch/.

Mantua Station Drug Co. ER visits linked to ADHD meds up sharply [Internet]. 2013 [cited 2015 Jun 18]. Available from: https://mantuastationrx.com/article.php?id=672868&category=DRAB

Larsson J. Confidential report reveals: Big Pharma trying to stop long-term safety studies of ADHD drugs (Ritalin, Concerta) [Internet]. In:TransWorldNews. 2010 [cited 2010 Apr 4]. Available from: http://www.transworldnews.com/NewsStory.aspx?StoryID=244733

The Dawn Report (DAWN). Emergency department visits involving Attention Deficit/Hyperactivity disorder stimulant medications [Internet]. 2013 [cited 2015 Jun 18]. Available from: http://archive.samhsa.gov/data/2k13/dawn073/sr073-add-adhd-medications.htm




DOI: https://doi.org/10.5712/rbmfc10(35)1014

Apontamentos

  • Não há apontamentos.




Direitos autorais 2015 Jean-Claude St-Onge

URL da licença: https://creativecommons.org/licenses/by-nc/3.0/br/

 

Desenvolvido por:

Logomarca da Lepidus Tecnologia